Vor Biopharma Inc.
VOR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $82 | $31 | $58 | $120 |
| Short-Term Investments | $10 | $106 | $173 | $88 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $4 | $7 | $7 |
| Total Curr. Assets | $97 | $141 | $237 | $214 |
| Property Plant & Equip (Net) | $42 | $50 | $57 | $23 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $2 | $2 | $0 |
| Tax Assets | $0 | $12 | $0 | $0 |
| Other NC Assets | $5 | $5 | $3 | $6 |
| Total NC Assets | $46 | $69 | $62 | $28 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $143 | $210 | $299 | $243 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $2 | $2 |
| Short-Term Debt | $4 | $4 | $3 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $11 | $8 | $7 |
| Total Curr. Liab. | $19 | $16 | $13 | $10 |
| LT Debt | $28 | $32 | $36 | $16 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $12 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $28 | $44 | $36 | $16 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $32 | $32 | $39 | $18 |
| Total Liabilities | $46 | $59 | $49 | $26 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$457 | -$340 | -$222 | -$130 |
| AOCI | $0 | -$0 | -$1 | $0 |
| Other Equity | $554 | $491 | $474 | $346 |
| Total Equity | $97 | $151 | $251 | $216 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $143 | $210 | $299 | $243 |
| Net Debt | -$50 | $4 | -$19 | -$102 |